Back to VANGUARD GROUP INC VANGUARD GROUP INC

HALOHALO
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in HALOZYME THERAPEUTICS INC

VANGUARD GROUP INC holds 11.6M shares of HALO (HALOZYME THERAPEUTICS INC), worth $778.5M as of 2025-Q4. The position was decreased (-0.5% shares). HALO represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$778.5M

Current Shares

11.6M

Total Value Change

+$40.3M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
11.6M
-0.5%
$778.5M0.0%$67.70
0
2025-Q3
Decreased
11.6M
-5.0%
$852.9M0.0%$73.29
0
2025-Q2
Decreased
12.2M
-4.6%
$637M0.0%$52.21
0
2025-Q1
Decreased
12.8M
-3.4%
$818.8M0.0%$63.84
0
2024-Q4
Increased
13.3M
+3.0%
$635M0.0%$47.99
32
2024-Q3
New
12.9M
-
$738.1M0.0%$56.97
44

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used